FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964394554> ?p ?o ?g. }

• W2964394554 endingPage "e024954" @default.
• W2964394554 startingPage "e024954" @default.
• W2964394554 abstract "Objective This study aimed to evaluate the association between metformin treatment and the risk of neurodegenerative disease (ND) among elderly adults with type 2 diabetes mellitus (T2DM). Design/Setting/Participants This retrospective longitudinal cohort study examined the effects of the length of metformin exposure on ND among elderly US veterans with T2DM and insulin treatment using the Veterans Affairs electronic medical record database. Primary and secondary outcome measures The primary clinical outcome was defined as diagnosis of ND including dementia, Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and mild cognitive impairment during the follow-up period. The secondary clinical outcomes were separately measured by AD, PD, HD, dementia and mild cognitive impairment. Result Adjusted by propensity score weight, a total of 5528 patients (mean age, 63.2±10.9 years; male, 98%; white, 60%) with a median follow-up of 5.2 years were selected. Those with ND or other mental disorders at baseline or who were on insulin for less than two-thirds of the study period were excluded. The incidence rate of ND was 11.48 per 1000 person-years among patients with metformin treatment, compared with 25.45 per 1000 person-years for those without metformin. Compared with no metformin use, 2–4 years and >4 years of metformin exposure were significantly associated with lower risk of ND (adjusted HR (aHR)=0.62, 95% CI 0.45 to 0.85; aHR=0.19, 95% CI 0.12 to 0.31, respectively), while metformin exposure in the first 2 years showed no significant influence. Conclusion We conclude that long-term metformin therapy (>2 years) was associated with lower incidence of ND among elderly veterans with T2DM. We need to conduct a study with more representative population and more robust method for causal inferences. Further investigation into the mechanism involved is needed along with randomised trials to confirm a potential neuroprotective effect of metformin." @default.
• W2964394554 created "2019-08-13" @default.
• W2964394554 creator A5017715587 @default.
• W2964394554 creator A5021569298 @default.
• W2964394554 creator A5034671525 @default.
• W2964394554 creator A5049291606 @default.
• W2964394554 creator A5069523303 @default.
• W2964394554 date "2019-07-01" @default.
• W2964394554 modified "2023-10-15" @default.
• W2964394554 title "Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus" @default.
• W2964394554 cites W118458551 @default.
• W2964394554 cites W1515929023 @default.
• W2964394554 cites W1553669285 @default.
• W2964394554 cites W1592335843 @default.
• W2964394554 cites W1593393815 @default.
• W2964394554 cites W1597817261 @default.
• W2964394554 cites W1854257503 @default.
• W2964394554 cites W1967239279 @default.
• W2964394554 cites W1970665848 @default.
• W2964394554 cites W1982795519 @default.
• W2964394554 cites W1996611755 @default.
• W2964394554 cites W2001599368 @default.
• W2964394554 cites W2005398842 @default.
• W2964394554 cites W2017422058 @default.
• W2964394554 cites W2019724009 @default.
• W2964394554 cites W2022952278 @default.
• W2964394554 cites W2027143183 @default.
• W2964394554 cites W2028911700 @default.
• W2964394554 cites W2032698104 @default.
• W2964394554 cites W2035437757 @default.
• W2964394554 cites W2035873080 @default.
• W2964394554 cites W2039741453 @default.
• W2964394554 cites W2040687775 @default.
• W2964394554 cites W2045441711 @default.
• W2964394554 cites W2048584554 @default.
• W2964394554 cites W2050640530 @default.
• W2964394554 cites W2057042201 @default.
• W2964394554 cites W2071068165 @default.
• W2964394554 cites W2086679674 @default.
• W2964394554 cites W2097897579 @default.
• W2964394554 cites W2120632975 @default.
• W2964394554 cites W2122522567 @default.
• W2964394554 cites W2126469714 @default.
• W2964394554 cites W2128367294 @default.
• W2964394554 cites W2137647318 @default.
• W2964394554 cites W2152471765 @default.
• W2964394554 cites W2160088494 @default.
• W2964394554 cites W2162361973 @default.
• W2964394554 cites W2166295381 @default.
• W2964394554 cites W2172193326 @default.
• W2964394554 cites W2211614117 @default.
• W2964394554 cites W2399549279 @default.
• W2964394554 cites W2473572751 @default.
• W2964394554 cites W2496321160 @default.
• W2964394554 cites W2517738083 @default.
• W2964394554 cites W4241136696 @default.
• W2964394554 cites W4243693606 @default.
• W2964394554 doi "https://doi.org/10.1136/bmjopen-2018-024954" @default.
• W2964394554 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6677947" @default.
• W2964394554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31366635" @default.
• W2964394554 hasPublicationYear "2019" @default.
• W2964394554 type Work @default.
• W2964394554 sameAs 2964394554 @default.
• W2964394554 citedByCount "82" @default.
• W2964394554 countsByYear W29643945542020 @default.
• W2964394554 countsByYear W29643945542021 @default.
• W2964394554 countsByYear W29643945542022 @default.
• W2964394554 countsByYear W29643945542023 @default.
• W2964394554 crossrefType "journal-article" @default.
• W2964394554 hasAuthorship W2964394554A5017715587 @default.
• W2964394554 hasAuthorship W2964394554A5021569298 @default.
• W2964394554 hasAuthorship W2964394554A5034671525 @default.
• W2964394554 hasAuthorship W2964394554A5049291606 @default.
• W2964394554 hasAuthorship W2964394554A5069523303 @default.
• W2964394554 hasBestOaLocation W29643945541 @default.
• W2964394554 hasConcept C126322002 @default.
• W2964394554 hasConcept C134018914 @default.
• W2964394554 hasConcept C167135981 @default.
• W2964394554 hasConcept C201903717 @default.
• W2964394554 hasConcept C2775969662 @default.
• W2964394554 hasConcept C2777180221 @default.
• W2964394554 hasConcept C2779134260 @default.
• W2964394554 hasConcept C2779306644 @default.
• W2964394554 hasConcept C2779483572 @default.
• W2964394554 hasConcept C2780323712 @default.
• W2964394554 hasConcept C2910068830 @default.
• W2964394554 hasConcept C555293320 @default.
• W2964394554 hasConcept C71924100 @default.
• W2964394554 hasConceptScore W2964394554C126322002 @default.
• W2964394554 hasConceptScore W2964394554C134018914 @default.
• W2964394554 hasConceptScore W2964394554C167135981 @default.
• W2964394554 hasConceptScore W2964394554C201903717 @default.
• W2964394554 hasConceptScore W2964394554C2775969662 @default.
• W2964394554 hasConceptScore W2964394554C2777180221 @default.
• W2964394554 hasConceptScore W2964394554C2779134260 @default.
• W2964394554 hasConceptScore W2964394554C2779306644 @default.
• W2964394554 hasConceptScore W2964394554C2779483572 @default.
• W2964394554 hasConceptScore W2964394554C2780323712 @default.

• next